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INTRODUCTION
Panic disorder (PD) is a chronic and often disabling psy-
chiatric condition (1). Some researches even reported increas-
ed cardiac mortality rate in patients with PD, and autonom-
ic dysregulation has been suggested to link between PD and
increased cardiac mortality (2, 3). Heart rate variability (HRV)
is known to be a noninvasive and useful method to assess auto-
nomic control of cardiac activity (4). HRV has attracted con-
siderable interest in clinical research (5, 6), and altered HRV
has been repeatedly found in patients with panic disorder (5-
8). Short-term spectral power analysis of HRV is typically
characterized by 3 major components: high frequency power
(HF), low frequency power (LF), and very low frequency power
(VLF). HF is known to reflect parasympathetic nervous activ-
ity, whereas LF is associated with both sympathetic and para-
sympathetic nervous activity (9). The absolute values of HF
and LF can be transformed into normalized units (nu) that
represent the relative values of each power component in pro-
portion to total power minus VLF component (9). LF/HF
and LF in normalized units are considered to mirror sympa-
thovagal balance (9). Yeragani et al. (10) reported a decrease
in the HF component and an increase in the LF component
in panic disorder patients compared with normal controls.
They also reported a significant increase in the sympathova-
gal ratio in the patient group after isoproterenol administra-
tion (8). These findings suggest an overall dysregulation of
autonomic activity in panic disorder. 
It remains unclear what the role of neural substrates is in
the relationship between HRV and serotonin transporter func-
tion. Catecholamines, such as norepinephrine and epinephrine,
have been assumed to be implicated in altered HRV in pati-
ents with PD. However, Alvarenga et al. (11) reported no
significant correlation between norepinephrine spillover rate
and HRV indexes. Abnormalities of serotonin transporter
(5-HTT) have been found in panic disorder, although results
about the synaptic serotonin state are still conflicting (12-14).
Lesch et al. (15) reported that hyperserotonergic state, result-
ing from impaired 5-HTT function, can lead to stimulation
of amygdala, and finally bring about anxiety or fear response.
In addition, serotonergic agents are known to relieve panic-
related symptoms effectively (16). Thus, the exploration of
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Platelet Serotonin Transporter Function and Heart Rate Variability 
in Patients with Panic Disorder
Many studies showed abnormal serotonin transporter (5-HTT) function and heart
rate variability (HRV) in panic disorder patients. The present study investigated the
relationship between HRV power spectral analysis findings and platelet serotonin
uptake in panic disorder patients. Short-term HRV over 5 min and platelet serotonin
transporter uptake parameters (Vmax and Km) were measured both in 45 patients with
panic disorder and in 30 age-matched normal healthy control subjects. Low frequen-
cy power (LF) normalized unit (nu) and LF/high frequency power (HF) were signifi-
cantly higher, whereas HF and HF nu were lower in the patient group than in the
control group. Vmax and Km were all significantly lower (i.e., reflects decreased 5-HTT
function) in patients with panic disorder than in normal controls. In the patient group,
Km was negatively correlated with LF/HF and LF nu whereas no such correlations
between them were found in the control group. By multivariate analysis based on
multiple hierarchical linear regression, a low Km independently predicted an increased
LF nu even after controlling for age, sex, and body mass index in the patient group.
These results suggest that impaired 5-HTT function is closely related to dysregula-
tion of autonomic nervous system in panic disorder.
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on the neural substrate of HRV and autonomic imbalance in
patients with PD. Although some studies have shown that
successful pharmacotherapy to affect 5-HTT function has been
associated with improved HRV findings in patients with
panic disorder, no data are available on the association bet-
ween HRV and a measureable index of serotonin uptake in
panic patients. 
The human platelet has been used as a useful peripheral
markers of central serotonergic neurons (17) because of the
difficulties of access to central nervous system. We aimed to
compare patients with panic disorder and normal healthy
controls in terms of HRV as well as platelet serotonin uptake,
and to determine the relationship between them in panic dis-
order patients.
MATERIALS AND METHODS
Particicipants
The study cohort consisted of 45 patients (23 men and 22
women) with panic disorder with/without agoraphobia, aged
from 20 to 55 yr (mean±SD, 38.8±7.70 yr). Sample char-
acteristics are listed in Table 1. Patients who met the DSM-
IV criteria for panic disorder with/without agoraphobia, were
diagnosed using the Structured Clinical Interview for DSM-
IV (SCID) (18). Panic disorder patients with a current major
medical or psychiatric illnesses, including heart disease, liver
or renal disease, diabetes mellitus, severe asthma, cerebrovas-
cular disease, mood disorder, other anxiety disorder, psychosis,
and current drug or alcohol abuse were excluded. The patients
in our study had a relatively short duration of illness (mean±
SD, 3.0±1.1 yr). To be eligible for the study, patients with
panic disorder should not have received any psychotropic med-
ications (except medication of benzodiazepines p.r.n.) for at
least 2 months before participating in the study. Thirty age-
matched normal healthy subjects (14 men and 16 women)
were recruited as control subjects using local advertisements
and referrals. All study subjects underwent a physical exam-
ination, electrocardiography, a complete blood count, blood
chemistry, and urinalysis. Subjects completed the Hamilton
Rating Scale for Anxiety (HAM-A) (19), the 17-item Hamil-
ton Rating Scale for Depression (HAM-D) (20), and the Panic
Disorder Severity Scale (PDSS)-Korean version (21). After
being given a complete description of the study, subjects pro-
vided written informed consent. The study was approved by
the Institutional Review Board of Samsung Medical Center.
Platelet [
3H]5-HT uptake assays
Venous blood was sampled from all 75 subjects into vacu-
tainer tubes containing acid citrate dextrose (ACD)-A bet-
ween 8:00 and 10:00 a.m. after overnight fasting. 5-HT up-
take parameters were measured within 2 hr of sample collec-
tion. Platelet-rich plasma (PRP) was prepared by centrifuga-
tion at 250 g for 15 min at a room temperature. Platelets for
[3H]-serotonin uptake assays were isolated by centrifuging PRP
twice at 3,000 g for 10 min, and then suspended in original
blood volumes of Ca2+ free Krebs-Hensleit buffer (pH 7.4).
Numbers of platelets were determined using an automatic
cell-counter in the impedance mode (Sysmex XE-2100, Kobe,
Japan). Aliquots of PRP were incubated in the presence of
[3H]5-HT (from 0.1 to 1.6 mM; final volume 500 mL) at 37℃
for 10 min, and the blocking of the binding reaction by 100
mM paroxetine was followed rapidly using INOTECH Glass
fiber filters (typeG-7). Filters were then washed twice with
5 mL of ice-cold saline (150 mM NaCl and 2% ethylene dia-
mine tetraacetic acid [EDTA]) and filter mat discs were dis-
tributed into vials containing 4 mL Ultima Gold F cocktail
solution (Perkin Elmer, Norwalk, CT). Radioactivities were
measured using a liquid scintillation in a Beckman L6500
Scintillation Counter. Platelet 5-HT uptake parameters were
calculated using the Michaelis-Menten equation using KELL
ver. 6.0 and Enzfitter for Windows (Biosoft
�, Cambridge,
UK).
Heart rate variability
Subjects were instrumented with an ProComp+ with elec-
trocardiogram (ECG) (Thought Technology Ltd., Quebec,
Canada) and rested for 30 min. Five-minutes of data were col-
lected at rest in a comfortable chair and stored in a comput-
er for subsequent review, artifact rejection, and calculation.
CardioPro program version 2.1 (Thought Technology Ltd.)
was used to perform time-domain analysis as well as spec-
tral power analyses by fast fourier transformation. Frequen-
cy domains including HF power (>0.15 Hz), LF power (0.05-
614 E.-H. Kang, I.-S. Lee, J.-E. Park, et al.
BMI, body mass index; HAM-A, the Hamilton Rating Scale for Anxiety;
HAM-D, the 17-item Hamilton Rating Scale for Depression; PDSS, the
Panic Disorder Severity Scale; STAI-S, the Spielberger State Anxiety
Inventory; NA, not, applicable.
Patients with
panic disorder
(n=45)
Normal control
subjects
(n=30)
P c2 or t
Sex (n, %) 0.82 0.44
Male 23 (51.1) 14 (46.7)
Female 22 (48.9) 16 (53.3)
With agoraphobia (n, %) 25 (55.6) NA NA NA
Age (yr) 38.8±7.7 35.9±4.1 1.23 0.22
BMI 23.4±2.6 24.8±2.6 1.48 0.14
Duration of illness (yr) 3.0±1.1 NA NA NA
HAM-A 19.0±7.3 5.0±4.7 9.30 <0.01
HAM-D 12.4±5.3 3.3±3.0 8.53 <0.01
PDSS 14.0±4.1 NA NA NA
STAI-S 46.4±11.8 32.9±7.0 5.47 <0.01
Table 1. Demographic and clinical characteristics0.15 Hz), VLF power (<0.05 Hz) were obtained. LF/HF ratio,
and HF nu and LF nu were also calculated.
Statistical analysis
The Student’s t-test and the Mann-Whitney U test were
used to analyze differences between groups in terms of HRV
indexes and platelet 5-HT uptake kinetic parameters. Cate-
gorical variables were analyzed using the chi-square test. Pear-
son correlation was used to examine the relationship between
HRV and platelet serotonin uptake parameters. We also per-
formed hierarchical multiple linear regression analysis of HRV
indexes (HF, LF/HF, and LF nu), which were viewed as depen-
dent measures, to determine whether 5-HT uptake parame-
ters predict HRV, after controlling for age, sex, and body mass
index. Analyses were run on the SPSS version 14.0 software.
The criterion for statistical significance was set at P<0.05.
RESULTS
Demographic and clinical characteristics of the subjects
were presented in the Table 1. As expected, the HAM-A,
HAM-D, and STAI-S scores were higher in panic patients
than those in controls (Table 1). In terms of HRV, LF/HF
ratio was higher (1.2±1.1 vs. 0.8±0.5, Z=2.06, P=0.039;
by the Mann-Whitney U test) whereas HF was lower in the
patients (142.5±192.0 vs. 227.0±251.8 ms2, Z=2.23, P=
0.03; by the Mann-Whitney U test). The Student’s t-test also
revealed that LF nu was higher and HF nu was lower in the
patients (46.8±17.7 vs. 38.3±16.5, t=-2.09, P=0.04 and
t=-2.09, P=0.04, respectively) (Table 2). There were no sig-
nificant differences in the means of HR, RR interval, SDNN,
and RMSSD between the patient group and healthy controls
(all P values >0.1). Respiration rates were not different bet-
ween the two groups (P=0.59). 
The Student’s t-test revealed that Vmax and Km values were
significantly lower in the patients than in normal controls
(352.5±180.0 vs. 490.4±272.3 pMol 5-HT/107platelet×
min 37℃, t=-3.31, P=0.01 and 759.3±407.0 vs. 1,288.5
±782.1 nM, t=-3.83, P=0.001, respectively). 
Pearson correlation analyses were performed between HRV
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*by Mann-Whitney U test.
Vmax, Platelet 5-HT uptake maximum velocity=pM 5-HT/10
7 platelet×min
37°C; Km, Michaelis-Mentens constant=nM; HR, heart rate per minutes;
SDNN, Standard deviation of normal to normal beat intervals (ms); RMSSD,
Root mean square of successive differences; LF, low frequency com-
ponent (ms
2); HF, high frequency component (ms
2); LF nu, LF normal-
ized unit; HF nu, HF normalized unit.
Patients with
panic disorder
(n=45)
Parameters
Normal control
subjects
(n=30)
P t or z
Vmax 352.5±18.0.0 490.4±272.3 3.31 0.01
Km 759.3±407.0 1,288.5±782.1 -3.83 <0.01
Mean HR (bpm) 66.6±9.9 62.8±7.4 1.76 0.08
Mean RR interval (ms) 919.1±128.3 966.6±111.9 -1.652 0.11
SDNN (ms) 37.8±17.1 42.7±14.3 -1.31 0.20
RMSSD (ms) 32.5±25.3 38.7±19.3 -1.13 0.26
HF 142.5±192.0 227.0±251.9 2.23* 0.03
LF 120.9±156.5 127.5±134.5 -0.19 0.42
LF/HF 1.2±1.1 0.8±0.5 2.06* 0.04
HF nu (%) 53.2±17.7 61.7±16.5 -2.09 0.04
LF nu (%) 46.8±17.7 38.3±16.5 2.09 0.04
Table 2. Platelet 5-HT uptake parameters and HRV indexes
Fig. 1. Correlation between Km and LF nu in patients with panic disorder and in normal control subjects. (A) Patients with panic disorder.
(B) Normal control subjects.
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PR
2 F b P
Step I 0.31 1.41 0.26
Age -0.12 0.49
Sex -0.24 0.13
BMI 0.16 0.38
Step II 0.46 2.71 0.04
Age -0.14 0.40
Sex -0.19 0.20
BMI 0.21 0.24
Km -0.35 0.02
Table 3. Hierarchical multiple linear regression analysis and the
prediction of sympathovagal index LF nu using Km in the patients
with panic disorder (n=45)indexes and 5-HT uptake parameters in both groups. In the
patient group, Km was found to be negatively correlated with
LF nu (r=-0.358, P=0.016; Fig. 1A) and LF/HF (r=-0.311,
P=0.037; Fig. 2A). There was no significant correlation bet-
ween Km and HF in the patient group (P>0.2). By multi-
variate analysis using multiple hierarchical linear regression,
a low Km was found to independently predict an elevated LF
nu after controlling for age, sex, and body mass index (DR2=
0.15, b=-0.35, P=0.02; Table 3). The significance of associa-
tion between LF/HF and Km disappeared after controlling
for such confounding variables (P>0.1). On the other hand,
no significant correlations were found between 5-HT uptake
parameters and HRV indices in the control group (all P val-
ues >0.1). We also examined the relationship between emo-
tional states (scores of the HAM-A, HAM-D, and STAI-S)
and HRV indices as well as Km since emotional states might
affect HRV parameters. However, we did not find any signifi-
cant correlation between them (all Pvalues >0.1).
DISCUSSION
Many researches have concluded that altered 5-HTT func-
tion and abnormalities in heart rate variability (HRV) are char-
acteristics of panic disorder (5, 6, 10, 12, 13, 22). However,
the relationship between platelet 5-HTT function and HRV
in panic disorder has yet to be known. To the best of our knowl-
edge, the present study is the first one to investigate the rela-
tionship between platelet 5-HT uptake function and HRV
in panic disorder.
There have been contradictory findings on the 5-HTT func-
tion in panic disorder (12, 13, 23). In the present study, platelet
5-HT uptake maximal velocity (Vmax) and its associated affin-
ity constant (Km) were found to be lower (i.e. increased affini-
ty) in panic disorder patients than in normal control subjects.
In terms of HRV indexes, decreased HF and increased LF/
HF and LF nu were noted in the panic patients, which sug-
gests that parasympathetic activity decreases and sympatho-
vagal balance increases in panic disorder patients. These find-
ings are consistent with some previous reports (8, 10). With
respect to 5-HTT function, recent genetic studies have shown
that anxiety disorder is associated with gene variants related
to reduced expression of 5-HTT both in the brain and on the
platelets, and reduced expression of 5-HTT leads to decreased
5-HT uptake (15, 24, 25). In line with these results, low Vmax
in this study can be considered to reflect a primary pathophys-
iological mechanism in panic disorder, resulting in seroton-
ergic overactivity in the synapses, whereas the low Km in this
study may be the result of secondary and compensatory pro-
cesses to the serotonergic overactivity.
Some preclinical studies provide an explanation for the inter-
actions between 5-HTT and the sympathoadrenal system.
Fox et al. (26) reported that 5-HTT knockout mice showed
exaggerated serotonin syndrome behavior and physiological
responses because of impaired 5-HT uptake function. Other
researchers have shown that decreased 5-HTT function is also
related to exaggerated sympathoadrenal and neuroendocrine
responses to stress (27, 28), and one function of 5-HTT is to
restrain adrenomedullary activation in response to stress (27).
Our results extend the relationship between the impaired 5-
HTT and dysregulation of autonomic nervous function to
panic disorder patients. 
Our results suggest that decreased 5-HTT function is relat-
ed to HRV abnormalities in patients with PD, and that Km
could be a quantitative predictor of autonomic dysfunction
in panic patients. Impaired HRV has been known to be asso-
ciated with increased cardiac morbidity and mortality, and
some researchers have reported that PD is related to increased
cardiac risk (2, 3). In the present study, panic disorder patients
showed decreased parasympathetic and increased sympatho-
vagal tones in terms of HRV indices. Taken together, abnor-
malities of 5-HTT function, specifically low Km, would be a
cardiac risk factor in patients with PD. 
There are some limitations in this study. This was a cross-
sectional study, limiting our inference on the causal direc-
tion. And the sample size was relatively small to generalize
our hypothesis in panic disorder. In addition, the healthy con-
trols were just age-matched subjects, although gender differ-
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Fig. 2. Correlation between Km and LF/HF in patients with panic disorder and in normal control subjects. (A) Patients with panic disorder.
(B) Normal control subjects.
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r=-0.039, P=0.837ence may affect the results. Several studies have reported con-
flicting results (29, 30) of HRV measures regarding gender
difference. However, sex distribution of the two groups was
not statistically different in this study, and gender did not
affect HRV indices in the regression model (Table 3). 
In conclusion, patients with panic disorder showed abnor-
malities in platelet 5-HTT function and HRV indexes, and
low affinity of 5-HTT could independently predict increased
sympathovagal activity in panic patients. Thus, we suggest
that impaired 5-HTT function may be closely related to dys-
regulation of autonomic nervous system in panic disorder.
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